Clinical Trials Logo

Hemangiomas clinical trials

View clinical trials related to Hemangiomas.

Filter by:
  • None
  • Page 1

NCT ID: NCT00866827 Completed - Clinical trials for Lymphatic Malformations

Airway Vascular Lesions

Start date: December 2002
Phase:
Study type: Observational

Controversy exists in the treatment of airway hemangiomas ranging from tracheotomy, various lasers, to open removal, none of which have proven to be a gold standard. Venous malformations of the airway are difficult to treat and also require laser therapy or open removal and often repeated treatments are required. Similarly airway lymphatic malformations can require multiple treatment modalities as well as multiple procedures and are infrequently eradicated when extensive. New uses for various lasers and differing treatment protocols are frequently developed. Review of the treatment modalities and efficacy of these methods is required. The goal of this research is to determine protocols for treatment of airway vascular malformation and to evaluate our results from treatment of these lesions.

NCT ID: NCT00577213 Completed - Clinical trials for Arteriovenous Malformations

Diagnosis of Hemangiomas and Vascular Malformations

Start date: February 2007
Phase: N/A
Study type: Observational

To develop a non-invasive, simple and affordable, measurement technique to differentiate hemangiomas from subtypes of VMS. The purpose of this study is to determine the best office based diagnositc instrument for differentiating the subtype of vascular lesions. The instrument must be simple and affordable so it can be used by primary car physicians in the doctor office. The procedure will be based on non-invasive and unharmful measurements that will be compared to the diagnosis from specialized physicians in this field and the final pathology.

NCT ID: NCT00576888 Completed - Hemangiomas Clinical Trials

Registry for Vascular Anomalies Associated With Coagulopathy

VAC
Start date: November 2007
Phase:
Study type: Observational

PURPOSE The purpose of this study is to learn more about multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT). MLT is a rare vascular disorder characterized by multiple congenital skin and visceral lesions, profound thrombocytopenia, and gastrointestinal bleeding. The skin lesions may appear red, brown or blue, often misdiagnosed as hemangiomas. The gastrointestinal tract, liver, and lungs are the most common internal organs involved. The severe thrombocytopenia (low platelets) is believed to be the result of platelet trapping within the skin and visceral vascular lesions. Severe and chronic gastrointestinal bleeding is common during infancy and early childhood. Although a relatively newly described entity, MLT was likely previously reported as hemangiomas, blue rubber bleb nevus syndrome, diffuse hemangiomatosis, Kasabach-Merritt phenomenon, and hereditary hemorrhagic telangiectasia. The term cutaneovisceral angiomatosis with thrombocytopenia is also a term used for this same disease. This study is a longitudinal cohort study of MLT to collect detailed clinical data on the distribution of disease, disease severity, and complications. This data will be used to create diagnostic criteria and an evaluation protocol for infants with this disease

NCT ID: NCT00312520 Completed - Hemangiomas Clinical Trials

Pulse Steroids Versus Oral Steroids in Problematic Hemangiomas of Infancy

Start date: July 2002
Phase: Phase 3
Study type: Interventional

The purpose of the study is to determine if pulse steroids are more efficacious and safer than the standard treatment with oral corticosteroids.